Literature DB >> 23860622

The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto's thyroiditis in Asian but not Caucasian populations: an updated meta-analysis.

Ming Feng1, Fang-Bin Zhang, Hong-Rong Deng.   

Abstract

The polymorphism +49A/G in the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) gene has been implicated in susceptibility to Hashimoto's thyroiditis (HT), but the findings are not clear-cut. This study aimed to investigate the association between CTLA-4 polymorphisms and HT risk using an updated meta-analysis. A meta-analysis was carried out of 14 previous studies that investigated the CTLA-4 +49A/G polymorphism and HT risk. +49A/G was associated with a significantly increased HT risk in both allele analysis and all genetic models (allele analysis: G vs. A: P < 0.001, OR = 1.379, 95 % CI = 1.244-1.529). Subgroup analysis by ethnicity showed a significantly increased HT risk with the G allele and all other genetic models in the Asian subgroup (P < 0.001). In the Caucasian subgroup, no significant association was detected between the CTLA-4 +49 G allele and HT, or in the genetic model analysis (P = 0.05). This gene-based analysis indicates that the cumulative effect of the +49A/G polymorphism in CTLA-4 is associated with HT in Asians, but appears to have no effect on HT in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860622     DOI: 10.1007/s12020-013-0014-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  22 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.

Authors:  Y J Park; H K Chung; D J Park; W B Kim; S W Kim; J J Koh; B Y Cho
Journal:  Thyroid       Date:  2000-06       Impact factor: 6.568

3.  Genetics of autoimmune thyroid disease in the Lebanese population.

Authors:  C Farra; J Awwad; A Fadlallah; G Sebaly; G Hage; M Souaid; H Ashkar; R Medlej; M H Gannageh; G Halaby
Journal:  J Community Genet       Date:  2012-03-06

4.  CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population.

Authors:  Jing Yang; Qiu Qin; Ni Yan; Yuan-Feng Zhu; Cui Li; Xiang-Ju Yang; Xuan Wang; Madhu Pandey; Peng Hou; Jin-An Zhang
Journal:  Endocrine       Date:  2011-08-25       Impact factor: 3.633

5.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

6.  Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.

Authors:  T Awata; S Kurihara; M Iitaka; S Takei; I Inoue; C Ishii; K Negishi; T Izumida; Y Yoshida; R Hagura; N Kuzuya; Y Kanazawa; S Katayama
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

7.  Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis.

Authors:  M Sahin; A Gursoy; M F Erdogan
Journal:  Int J Immunogenet       Date:  2009-04       Impact factor: 1.466

8.  CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease.

Authors:  Tomás Dallos; Magdalena Avbelj; L'ubomír Barák; Jirina Zapletalová; Zuzana Pribilincová; Mária Krajcírová; L'udmila Kostálová; Tadej Battelino; László Kovács
Journal:  Neuro Endocrinol Lett       Date:  2008-06       Impact factor: 0.765

9.  CTLA4 gene polymorphisms in children and adolescents with autoimmune thyroid diseases.

Authors:  Ediz Yeşilkaya; Altuğ Koç; Aysun Bideci; Orhun Camurdan; Mehmet Boyraz; Ozgür Erkal; Mehmet Ali Ergun; Peyami Cinaz
Journal:  Genet Test       Date:  2008-09

10.  CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.

Authors:  J Braun; H Donner; T Siegmund; P G Walfish; K H Usadel; K Badenhoop
Journal:  Tissue Antigens       Date:  1998-05
View more
  5 in total

1.  Systemic nickel allergic syndrome as an immune-mediated disease with an increased risk for thyroid autoimmunity.

Authors:  Massimiliano Andrioli; Pierpaolo Trimboli; Dominga Maio; Luca Persani; Mauro Minelli
Journal:  Endocrine       Date:  2015-03-21       Impact factor: 3.633

2.  Association and gene-gene interaction analyses for polymorphic variants in CTLA-4 and FOXP3 genes: role in susceptibility to autoimmune thyroid disease.

Authors:  Nusrath Fathima; Parimala Narne; Mohammed Ishaq
Journal:  Endocrine       Date:  2019-02-15       Impact factor: 3.633

3.  Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.

Authors:  Jinshan He; Jingcheng Wang; Daxin Wang; Shanhe Dai; Tangyun Yv; Pengtao Chen; Renshi Ma; Chunyv Diao; Guohua Lv
Journal:  Endocrine       Date:  2014-03       Impact factor: 3.633

4.  The possible role of CD4⁺CD25(high)Foxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis.

Authors:  Haibo Xue; Xiurong Yu; Lei Ma; Shoujun Song; Yuanbin Li; Li Zhang; Tingting Yang; Huan Liu
Journal:  Endocrine       Date:  2015-03-13       Impact factor: 3.633

5.  Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.

Authors:  Wei-Hsin Ting; Ming-Nan Chien; Fu-Sung Lo; Chao-Hung Wang; Chi-Yu Huang; Chiung-Ling Lin; Wen-Shan Lin; Tzu-Yang Chang; Horng-Woei Yang; Wei-Fang Chen; Ya-Ping Lien; Bi-Wen Cheng; Chao-Hsu Lin; Chia-Ching Chen; Yi-Lei Wu; Chen-Mei Hung; Hsin-Jung Li; Chon-In Chan; Yann-Jinn Lee
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.